.jpg)
.png)
All
The National Lipid Association (NLA) is seeking nominations for the Chief Science Officer (CSO) position for the 2020-2023 term. The position overview, required qualifications, nomination criteria, selection process, and timeline can be found on the NLA website at: https://www.lipid.org/... more
The new ICD-10 Codes released by the Center for Medicare & Medicaid Services (CMS) are now in effect. The codes became effective October 1, 2016. The two new specific codes for FH are: E78.01: Familial hypercholesterolemia Z83.42: Family history of familial... more
The Philadelphia Lipid and Atherosclerosis Club PLAC Wednesday, December 10, 2014 6:00 PM "CT scan for predicting cardiovascular risk” Presented by: Douglas Jacoby, MD, FACC Division of Cardiovascular Medicine University of Pennsylvania... more
Thank you for participating in the 21 Day Challenge. Below please find your opportunity to reflect on today's activity. Note: Chapter and Reflection are the only mandatory fields, though the NLA hopes to collect participant demographic data for improvement of DEI within our organization. more
Location: Temple, Texas Position Type: Full-Time Physician Key Responsibilities: • Provide expert management of lipid disorders using pharmacologic therapies including statins, PCSK9 inhibitors, Ezetimibe, Bempedoic Acid, and siRNA injectables. • Refer appropriate... more
As clinicians with the privilege of taking care of patients with Familial Chylomicronemia Syndrome (FCS), we support your efforts to urge the United States Food and Drug Administration (FDA) to approve volanesorsen, particularly in light of there currently being no other effective medical therapy... more
The 2016 American College of Cardiology (ACC) Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk By Carl Orringer, MD, FNLA Following “LDL Think Tank” meeting convened by ACC in October 2015, a meeting attended by... more
Established by leading researchers as a not-for-profit organisation, the PCSK9 Education and Research Forum will provide healthcare professionals with open access to electronic and multimedia platforms providing real-time reporting of significant developments and news; authoritative analysis and... more
The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more